These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 35962624)
1. Benzimidazole-based protein kinase inhibitors: Current perspectives in targeted cancer therapy. Ali AM; Tawfik SS; Mostafa AS; Massoud MAM Chem Biol Drug Des; 2022 Nov; 100(5):656-673. PubMed ID: 35962624 [TBL] [Abstract][Full Text] [Related]
2. Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors. Li Y; Tan C; Gao C; Zhang C; Luan X; Chen X; Liu H; Chen Y; Jiang Y Bioorg Med Chem; 2011 Aug; 19(15):4529-35. PubMed ID: 21724404 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and in vitro evaluation of 6-amide-2-aryl benzoxazole/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase. Yuan X; Yang Q; Liu T; Li K; Liu Y; Zhu C; Zhang Z; Li L; Zhang C; Xie M; Lin J; Zhang J; Jin Y Eur J Med Chem; 2019 Oct; 179():147-165. PubMed ID: 31252306 [TBL] [Abstract][Full Text] [Related]
4. Insights into the structure and drug design of benzimidazole derivatives targeting the epidermal growth factor receptor (EGFR). Abdullah MN; Ali Y; Abd Hamid S Chem Biol Drug Des; 2022 Dec; 100(6):921-934. PubMed ID: 34651438 [TBL] [Abstract][Full Text] [Related]
5. Discovery of quinazolin-4-amines bearing benzimidazole fragments as dual inhibitors of c-Met and VEGFR-2. Shi L; Wu TT; Wang Z; Xue JY; Xu YG Bioorg Med Chem; 2014 Sep; 22(17):4735-44. PubMed ID: 25082515 [TBL] [Abstract][Full Text] [Related]
6. Molecular docking simulation, synthesis and 3D pharmacophore studies of novel 2-substituted-5-nitro-benzimidazole derivatives as anticancer agents targeting VEGFR-2 and c-Met. Ibrahim HA; Awadallah FM; Refaat HM; Amin KM Bioorg Chem; 2018 Apr; 77():457-470. PubMed ID: 29453077 [No Abstract] [Full Text] [Related]
7. Pharmacophore based drug design and synthesis of oxindole bearing hybrid as anticancer agents. Pathak A; Pandey V; Raj Pokharel Y; Devaraji V; Ali A; Haider K; Saad S; Dewangan RP; Siddiqui N; Shahar Yar M Bioorg Chem; 2021 Nov; 116():105358. PubMed ID: 34544029 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors. Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and docking studies of benzimidazole derivatives as potential EGFR inhibitors. Celik İ; Ayhan-Kılcıgil G; Guven B; Kara Z; Gurkan-Alp AS; Karayel A; Onay-Besikci A Eur J Med Chem; 2019 Jul; 173():240-249. PubMed ID: 31009910 [TBL] [Abstract][Full Text] [Related]
10. Repurposing of Benzimidazole Scaffolds for HER2 Positive Breast Cancer Therapy: An Jubie S; Durai U; Latha S; Ayyamperumal S; Wadhwani A; Prabha T Curr Drug Res Rev; 2021; 13(1):73-83. PubMed ID: 32955008 [TBL] [Abstract][Full Text] [Related]
11. Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors. Shi L; Wu TT; Wang Z; Xue JY; Xu YG Eur J Med Chem; 2014 Sep; 84():698-707. PubMed ID: 25064347 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors. Akhtar MJ; Khan AA; Ali Z; Dewangan RP; Rafi M; Hassan MQ; Akhtar MS; Siddiqui AA; Partap S; Pasha S; Yar MS Bioorg Chem; 2018 Aug; 78():158-169. PubMed ID: 29571113 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro antiproliferative activity and kinase profile of new benzimidazole and benzotriazole derivatives. Chojnacki K; Wińska P; Skierka K; Wielechowska M; Bretner M Bioorg Chem; 2017 Jun; 72():1-10. PubMed ID: 28340404 [TBL] [Abstract][Full Text] [Related]
14. Indazole Derivatives: Promising Anti-tumor Agents. Wan Y; He S; Li W; Tang Z Anticancer Agents Med Chem; 2018; 18(9):1228-1234. PubMed ID: 29745343 [TBL] [Abstract][Full Text] [Related]
15. New Molecular Targets of Anticancer Therapy - Current Status and Perspectives. Zajac M; Muszalska I; Jelinska A Curr Med Chem; 2016; 23(37):4176-4220. PubMed ID: 27528054 [TBL] [Abstract][Full Text] [Related]
16. Aurora-B kinase inhibitors for cancer chemotherapy. Yeung SC; Gully C; Lee MH Mini Rev Med Chem; 2008 Dec; 8(14):1514-25. PubMed ID: 19075809 [TBL] [Abstract][Full Text] [Related]
17. Benzimidazole derivatives as kinase inhibitors. Garuti L; Roberti M; Bottegoni G Curr Med Chem; 2014; 21(20):2284-98. PubMed ID: 24533813 [TBL] [Abstract][Full Text] [Related]
20. Development of 2-(4-pyridyl)-benzimidazoles as PKN2 chemical tools to probe cancer. Scott F; Fala AM; Pennicott LE; Reuillon TD; Massirer KB; Elkins JM; Ward SE Bioorg Med Chem Lett; 2020 Apr; 30(8):127040. PubMed ID: 32085971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]